Therapy News and Research

RSS

HPV-positive patients with OPSCC show higher overall survival rate than HPV-negative patients

A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy in the Radiation Therapy Oncology Group (RTOG) studies 0129 or 0522 found that HPV-positive patients had a higher overall survival (OS) rate than HPV-negative patients (at two years post-treatment, 54.6 percent vs. 27.6 percent, respectively), according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.

20 Feb 2014

High-potency statins offer improved chance of survival in heart attack patients

A study looking at the data of thousands of patients who suffered heart attacks has suggested treatment with high-potency statins offers a significantly improved chance of survival compared to those taking normal statins.

20 Feb 2014

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Pharmacyclics, Inc. today reported financial results and recent developments for the quarter and year ended December 31, 2013.

20 Feb 2014

Psychotherapies have specific effects on psychosis symptoms

There are small but robust differences in the effects of different psychotherapies on psychosis symptoms, say the authors of a meta-analysis.

20 Feb 2014

Medicines that mimic body's natural systems can prevent debilitating side effects

Debilitating side effects associated with prescription medication for some of today's most common conditions could be eradicated if they mimicked the body's natural hormone secretion cycles, a new report has said.

20 Feb 2014

Cyberonics receives CE Mark approval in Europe for AspireSR generator

Cyberonics, Inc. announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator.

20 Feb 2014

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Larry Ambrose woke up one night, wandered into his kitchen but couldn't completely read the time on his microwave. A few days later when he noticed his blood pressure was unusually high, he went to the hospital and was diagnosed as having a stroke.

From Medtronic 20 Feb 2014

Researchers propose new treatment to prevent mucositis in cancer patients

Experimental work pointing to a therapy for alleviating mucositis -- a common, severe side effect of chemotherapy and irradiation of cancer patients or patients prepared for bone marrow transplantation - has been achieved by an international team of researchers from the US and Israel headed by scientists at the Hebrew University of Jerusalem.

20 Feb 2014

Lung cancer patients with Del19 mutation benefit most from afatinib

Afatinib has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).

20 Feb 2014

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.

20 Feb 2014

Ten researchers receive 2014 Heinz Maier-Leibnitz Prizes

This year's recipients of the most important prize for early career researchers in Germany have been announced. The selection committee, appointed by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and the German Federal Ministry of Education and Research (BMBF), has chosen ten researchers, three women and seven men, to receive the 2014 Heinz Maier-Leibnitz Prizes.

20 Feb 2014

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.

20 Feb 2014

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.

20 Feb 2014

Researchers develop screening assay that quickly assesses nearly 1,500 compounds' effect on estrogen

A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.

20 Feb 2014

Purdue’s new innovation improves drug therapies by making real-time decisions about treatment options

Oncologists and cancer patients could improve the results of drug therapies by making real-time decisions about treatment options using an innovation developed in Purdue University's College of Pharmacy.

20 Feb 2014

Vaccine-based clinical trial to improve survival outcomes of kidney cancer patients

The Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute has opened a novel Phase III, vaccine-based clinical trial aimed at providing kidney cancer patients long-term control of their disease.

20 Feb 2014

Premature babies who receive interventional therapy plus mother's voice learn to eat efficiently

Premature babies who receive an interventional therapy combining their mother's voice and a pacifier-activated music player learn to eat more efficiently and have their feeding tubes removed sooner than other preemies, according to a Monroe Carell Jr. Children's Hospital at Vanderbilt study published today in Pediatrics.

20 Feb 2014

Breast cancer patients receiving radiotherapy show decreased fatigue as result of CBTH

Breast cancer patients receiving radiotherapy showed decreased fatigue as a result of cognitive behavioral therapy plus hypnosis (CBTH), according to a study recently published in the Journal of Clinical Oncology.

20 Feb 2014

NIH-funded session in Bethesda to heighten awareness of underactive bladder

Underactive bladder, estimated to affect more than 20 percent of the elderly population, is an unrecognized disease that has a major influence on the health and independence of seniors.

20 Feb 2014

Addition of confocal laser endomicroscopy to HDWLE improves diagnosis of Barrett's esophagus

New research shows that the addition of confocal laser endomicroscopy to high-definition white-light endoscopy enables improved real-time endoscopic diagnosis of Barrett's esophagus dysplasia (neoplastic tissue) by using targeted biopsies of abnormal mucosa to reduce unnecessary mucosal biopsies and potentially reduce costs.

20 Feb 2014

Therapy News and Research

HPV-positive patients with OPSCC show higher overall survival rate than HPV-negative patients

High-potency statins offer improved chance of survival in heart attack patients

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Psychotherapies have specific effects on psychosis symptoms

Medicines that mimic body's natural systems can prevent debilitating side effects

Cyberonics receives CE Mark approval in Europe for AspireSR generator

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Researchers propose new treatment to prevent mucositis in cancer patients

Lung cancer patients with Del19 mutation benefit most from afatinib

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Ten researchers receive 2014 Heinz Maier-Leibnitz Prizes

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Researchers develop screening assay that quickly assesses nearly 1,500 compounds' effect on estrogen

Purdue’s new innovation improves drug therapies by making real-time decisions about treatment options

Vaccine-based clinical trial to improve survival outcomes of kidney cancer patients

Premature babies who receive interventional therapy plus mother's voice learn to eat efficiently

Breast cancer patients receiving radiotherapy show decreased fatigue as result of CBTH

NIH-funded session in Bethesda to heighten awareness of underactive bladder

Addition of confocal laser endomicroscopy to HDWLE improves diagnosis of Barrett's esophagus

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News